These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 34927126)

  • 1. Long-term impact of HPV vaccination and COVID-19 pandemic on oropharyngeal cancer incidence and burden among men in the USA: A modeling study.
    Damgacioglu H; Sonawane K; Chhatwal J; Lairson DR; Clifford GM; Giuliano AR; Deshmukh AA
    Lancet Reg Health Am; 2022 Apr; 8():100143. PubMed ID: 34927126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based impact projections of single-dose human papillomavirus vaccination in India: a modelling study.
    Man I; Georges D; de Carvalho TM; Ray Saraswati L; Bhandari P; Kataria I; Siddiqui M; Muwonge R; Lucas E; Berkhof J; Sankaranarayanan R; Bogaards JA; Basu P; Baussano I
    Lancet Oncol; 2022 Nov; 23(11):1419-1429. PubMed ID: 36174583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increasing HPV vaccination coverage to prevent oropharyngeal cancer: A cost-effectiveness analysis.
    Choi SE; Choudhary A; Huang J; Sonis S; Giuliano AR; Villa A
    Tumour Virus Res; 2022 Jun; 13():200234. PubMed ID: 34974194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projected Association of Human Papillomavirus Vaccination With Oropharynx Cancer Incidence in the US, 2020-2045.
    Zhang Y; Fakhry C; D'Souza G
    JAMA Oncol; 2021 Oct; 7(10):e212907. PubMed ID: 34473210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The incidence of oropharyngeal cancer and rate of human papillomavirus vaccination coverage in Florida, 2011 through 2015.
    Khan N; Tomar SL
    J Am Dent Assoc; 2020 Jan; 151(1):51-58. PubMed ID: 31902400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study.
    Luo Q; O'Connell DL; Yu XQ; Kahn C; Caruana M; Pesola F; Sasieni P; Grogan PB; Aranda S; Cabasag CJ; Soerjomataram I; Steinberg J; Canfell K
    Lancet Public Health; 2022 Jun; 7(6):e537-e548. PubMed ID: 35660215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covid-19 pandemic and equity of global human papillomavirus vaccination: descriptive study of World Health Organization-Unicef vaccination coverage estimates.
    Casey RM; Akaba H; Hyde TB; Bloem P
    BMJ Med; 2024; 3(1):e000726. PubMed ID: 38293682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic models.
    Brisson M; Bénard É; Drolet M; Bogaards JA; Baussano I; Vänskä S; Jit M; Boily MC; Smith MA; Berkhof J; Canfell K; Chesson HW; Burger EA; Choi YH; De Blasio BF; De Vlas SJ; Guzzetta G; Hontelez JAC; Horn J; Jepsen MR; Kim JJ; Lazzarato F; Matthijsse SM; Mikolajczyk R; Pavelyev A; Pillsbury M; Shafer LA; Tully SP; Turner HC; Usher C; Walsh C
    Lancet Public Health; 2016 Nov; 1(1):e8-e17. PubMed ID: 29253379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
    Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
    Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct benefit of vaccinating boys along with girls against oncogenic human papillomavirus: bayesian evidence synthesis.
    Bogaards JA; Wallinga J; Brakenhoff RH; Meijer CJ; Berkhof J
    BMJ; 2015 May; 350():h2016. PubMed ID: 25985328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of human papillomavirus vaccination intent for oropharyngeal cancer prevention among gay and bisexual men living in the United States.
    Stull C; Bennis SL; Rosser BRS; Wilkerson JM; Zoschke IN; Jiang Z; Nyitray AG; Khariwala SS; Ross MW
    J Am Dent Assoc; 2024 Jan; 155(1):26-38.e1. PubMed ID: 37988048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual Report to the Nation on the Status of Cancer, 1975-2009, featuring the burden and trends in human papillomavirus(HPV)-associated cancers and HPV vaccination coverage levels.
    Jemal A; Simard EP; Dorell C; Noone AM; Markowitz LE; Kohler B; Eheman C; Saraiya M; Bandi P; Saslow D; Cronin KA; Watson M; Schiffman M; Henley SJ; Schymura MJ; Anderson RN; Yankey D; Edwards BK
    J Natl Cancer Inst; 2013 Feb; 105(3):175-201. PubMed ID: 23297039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of HPV vaccination on the incidence of oropharyngeal cancers in men: a review.
    Macilwraith P; Malsem E; Dushyanthen S
    Infect Agent Cancer; 2023 Apr; 18(1):24. PubMed ID: 37095546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is 2045 the best we can do? Mitigating the HPV-related oropharyngeal cancer epidemic.
    Schuman A; Anderson KS; Day AT; Ferrell J; Sturgis EM; Dahlstrom KR
    Expert Rev Anticancer Ther; 2022 Jul; 22(7):751-761. PubMed ID: 35679626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations in Human Papillomavirus-Associated Oropharyngeal Cancer Screening: A Review.
    Day AT; Fakhry C; Tiro JA; Dahlstrom KR; Sturgis EM
    JAMA Otolaryngol Head Neck Surg; 2020 Jul; 146(7):656-664. PubMed ID: 32379293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening.
    Boily MC; Barnabas RV; Rönn MM; Bayer CJ; van Schalkwyk C; Soni N; Rao DW; Staadegaard L; Liu G; Silhol R; Brisson M; Johnson LF; Bloem P; Gottlieb S; Broutet N; Dalal S
    EClinicalMedicine; 2022 Dec; 54():101754. PubMed ID: 36583170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.
    Castanon A; Landy R; Pesola F; Windridge P; Sasieni P
    Lancet Public Health; 2018 Jan; 3(1):e34-e43. PubMed ID: 29307386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multi-state Evaluation of Oral Health Students' Knowledge of Human Papillomavirus-Related Oropharyngeal Cancer and HPV Vaccination.
    Rutkoski H; Tay DL; Dixon BL; Pinzon LM; Mooney R; Winkler JR; Kepka D
    J Cancer Educ; 2020 Oct; 35(5):1017-1025. PubMed ID: 31222578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
    Cody P; Tobe K; Abe M; Elbasha EH
    BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.